PeerVoice Internal Medicine Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 20m. Bisher sind 618 Folge(n) erschienen. .

Gesamtlänge aller Episoden: 10 days 16 hours 40 minutes

subscribe
share






If You Suspect, Test! The Important First Steps to Preventing the Devastating Consequences of Hepatitis


If You Suspect, Test! The Important First Steps to Preventing the Devastating Consequences of Hepatitis


share








 April 23, 2021  19m
 
 

Can Long-Acting Injectables Make a Difference in HIV?


Can Long-Acting Injectables Make a Difference in HIV?


share








 April 6, 2021  25m
 
 

Optimising Standard of Care for Patients With Axial Spondyloarthropathies: Why Gender Matters!


Optimising Standard of Care for Patients With Axial Spondyloarthropathies: Why Gender Matters!


share








 April 3, 2021  22m
 
 

Optimising HBV Treatment Outcomes Whilst We Hunt for a Cure


Optimising HBV Treatment Outcomes Whilst We Hunt for a Cure


share








 March 20, 2021  17m
 
 

Understanding Hypercapnia in Adult Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes


Understanding Hypercapnia in Adult Respiratory Distress Syndrome: The Quest for Optimal Patient Outcomes


share








 March 13, 2021  12m
 
 

Expert Perspectives on Disease Progression in Axial Spondyloarthritis


Expert Perspectives on Disease Progression in Axial Spondyloarthritis


share








 March 11, 2021  17m
 
 

Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments


Evolving the Treatment Paradigm in Metastatic HER2-Positive Breast Cancer: The Ongoing Story of Emerging Treatments


share








 February 25, 2021  15m
 
 

GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!


GnRH Antagonist vs LHRH Agonist: To Desensitize or To Inhibit, That Is the Question!


share








 February 18, 2021  19m
 
 

The First Biologic in IBD: When, Which, and Why?


The First Biologic in IBD: When, Which, and Why?


share








 February 13, 2021  29m
 
 

Practical Strategies in Optimising Subcutaneous Immunoglobulin Replacement Therapy


Practical Strategies in Optimising Subcutaneous Immunoglobulin Replacement Therapy


share








 February 11, 2021  1h1m